To confirm the relationship between AMPKα2 and FO anti-atherosclerosis, we enrolled 349 patients (270 CAD, 79 non-CAD) from the General Hospital of Northern theater command between April 2017 and June 2019. Here, PRKAA2 is linked to coronary artery disorder.